✦ LIBER ✦

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

✍ Scribed by Keane, Joseph; Gershon, Sharon; Wise, Robert P.; Mirabile-Levens, Elizabeth; Kasznica, John; Schwieterman, William D.; Siegel, Jeffrey N.; Braun, M. Miles

Book ID: 115464564
Publisher: Massachusetts Medical Society
Year: 2001
Tongue: English
Weight: 195 KB
Volume: 345
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejmoa011110

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Auftreten von Tuberkuloseerkrankungen un

Auftreten von Tuberkuloseerkrankungen unter der Therapie mit dem Tumor Nekrose Faktor-α neutralisierenden Antikörper Infliximab Referierte Originalarbeit: Keane J, Gershorn S, Wise RP et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 345:1098–1104

✍ Christian Antoni 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 German ⚖ 52 KB

Tuberculosis associated with therapy aga

Tuberculosis associated with therapy against tumor necrosis factor α

✍ Kevin L. Winthrop; Jeffrey N. Siegel; John Jereb; Zachary Taylor; Michael F. Iad 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

Vasculitis Associated With Tumor Necrosi

Vasculitis Associated With Tumor Necrosis Factor-α Inhibitors

✍ Sokumbi, Olayemi; Wetter, David A.; Makol, Ashima; Warrington, Kenneth J. 📂 Article 📅 2012 🏛 Mayo Clinic 🌐 English ⚖ 529 KB

Infections Associated with Tumor Necrosi

Infections Associated with Tumor Necrosis Factor-α Antagonists

✍ David J. Rychly; Joseph T. DiPiro 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Listeria monocytogenes infection as a co

Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α–neutralizing agents

✍ Nancy R. Slifman; Sharon K. Gershon; Jong-Hoon Lee; Evelyne T. Edwards; M. Miles 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Abstract ## Objective Tumor necrosis factor α (TNFα) has been implicated in the pathogenesis of certain inflammatory diseases. Two TNFα‐neutralizing agents are licensed in the US. Infliximab is licensed for the treatment of Crohn's disease (CD) and, when used with methotrexate, for the treatmen

Invasive Pulmonary Aspergillosis Soon Af

Invasive Pulmonary Aspergillosis Soon After Therapy With Infliximab, a Tumor Necrosis Factor‐Alpha‐Neutralizing Antibody: A Possible Healthcare‐Associated Case? •

✍ Francesco G. De Rosa, MD; David Shaz, MD; Anthony C. Campagna, MD; Paul F. Della 📂 Article 📅 2003 🏛 University of Chicago Press 🌐 English ⚖ 198 KB